Advances in Hematological Malignancies
Recent centuries have witnessed remarkable strides in the field of hematological malignancies. Novel therapies such as targeted therapy, immunotherapies, and gene editing are altering the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative techniques, offering potential for more effective treatment option